Persistence with initial therapy low in type 2 diabetes mellitus

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.386, 2002-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination lipid therapy in type 2 diabetes mellitus

By Vergèès Bruno

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 9, 2011-06 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus

By Rajagopalan R. Perez A. Ye Z. Khan M. Murray F.T.

Drugs & Aging, Vol. 21, Iss. 4, 2004-01 ,pp. : 259-271

Adis International

Access to resources Recommend Favorite

Optimising Therapy for Insulin-Treated Type 2 Diabetes Mellitus

By Hermann L.

Drugs & Aging, Vol. 17, Iss. 4, 2000-10 ,pp. : 283-294

Adis International

Access to resources Recommend Favorite

Liraglutide has demonstrated efficacy as an add-on therapy for type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus

By Guarino Elisa Nigi Laura Patti Aurora Fondelli Cecilia Dotta Francesco

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1377-1384

Informa Healthcare

Access to resources Recommend Favorite